AI Precision Testing Will Be Standard Of Care Within 5 Years, Says Waiv CEO After $33M Raise

 
• By Shubham Singh
  
The company is building AI-powered diagnostic tools designed to extract clinically actionable insights from digital pathology images and multimodal clinical data. Picture Courtesy: Waiv

More from Oncology

More from Device Area